About US
Contact us
-
Indian firm Zydus Cadila purchases two ANDAs from TevaIndian pharmaceutical company Zydus Cadila has acquired two abbreviated new drug applications (ANDAs) from Israeli-American pharmaceutical company Teva. The two ANDAs are being sold out by Teva as a2016/6/21
-
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, tooNEW ORLEANS--Johnson & Johnson’s Invokana is already coming up big for the company as a treatment for Type 2 diabetes. And the pharma giant recently got some encouraging signs that it may one day2016/6/20
-
Teva pulls migraine patch Zecuity on reports of burning, scarringSo much for the $114 million Teva shelled out to get its hands on Zecuity developer NuPathe. After less than a year on the market, the Israeli drugmaker is pulling the migraine patch. Monday, the com2016/6/20
-
NIH-funded study finds proper maternal folate levels reduce childhood obesityA study led by the National Institutes of Health (NIH)-funded researchers has revealed that proper maternal folate levels during pregnancy may protect children from a future risk of obesity, especiall2016/6/17
-
Researchers discover heart drug Darapladibm can reduce diabetes related blindnessResearchers at University College London (UCL) and Queen's University Belfast have found that a drug Darapladibm, which was originally developed to treat cardiovascular disease, has the ability to red2016/6/17
-
New survey reveals UK failing to meet European standards for lung cancer treatmentData collected from a new survey of 100 doctors has revealed that the treatment of patients with advanced lung cancer in the UK has failed to meet desired European standards. The doctors who are spec2016/6/16
-
FDA grants Breakthrough Therapy Designation for Shire’s SHP621 and SHP625Biopharmaceutical company Shire has received the US Food and Drug Administration's (FDA) breakthrough therapy designation for its two investigational drug candidates. The investigational drugs are in2016/6/16
-
Charleston Laboratories and Daiichi Sankyo’s NDA for CL-108 receives FDA acceptanceThe collaboration of US-based pharmaceutical company Charleston Laboratories and Japanese pharmaceutical company Daiichi Sankyo has received acceptance from the US Food and Drug Administration (FDA) f2016/6/15
-
US WRAIR and Beth Israel Deaconess to conduct preclinical research on Zika vaccine candidateScientists from US Walter Reed Army Institute of Research (WRAIR) have collaborated with Beth Israel Deaconess Medical Centre in Boston, Massachusetts, to conduct preclinical research on a Zika vaccin2016/6/15
-
FDA takes legal action against 4,402 unlawful drug-selling websitesThe US Food and Drug Administration (FDA) and the international regulatory and law enforcement agencies have taken action against 4,402 websites that illegally sell dangerous and unapproved prescripti2016/6/14